HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression

Blanchet, Matthieu; Angelo, Léna; Tetreault, Yasmine; Khabir, Marwa; Sureau, Camille; Vaillant, Andrew et Labonté, Patrick ORCID: https://orcid.org/0000-0001-7262-3125 (2024). HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression Viruses , vol. 16 , nº 4:532. pp. 1-16. DOI: 10.3390/v16040532.

Prévisualisation

PDF - Version publiée Disponible sous licence Creative Commons Attribution. Télécharger (6MB) | Prévisualisation

Résumé

Individuals chronically infected with hepatitis B virus (HBV) and hepatitis Delta virus (HDV) present an increased risk of developing cirrhosis and hepatocellular carcinoma in comparison to HBV mono-infected individuals. Although HDV only replicates in individuals coinfected or superinfected with HBV, there is currently no in vitro model that can stably express both viruses simultaneously, mimicking the chronic infections seen in HBV/HDV patients. Here, we present the HepG2BD cell line as a novel in vitro culture system for long-term replication of HBV and HDV. HepG2BD cells derive from HepG2.2.15 cells in which a 2 kb HDV cDNA sequence was inserted into the adeno-associated virus safe harbor integration site 1 (AAVS1) using CRISPR-Cas9. A Tet-Off promoter was placed 5' of the genomic HDV sequence for reliable initiation/repression of viral replication and secretion. HBV and HDV replication were then thoroughly characterized. Of note, non-dividing cells adopt a hepatocyte-like morphology associated with an increased production of both HDV and HBV virions. Finally, HDV seems to negatively interfere with HBV in this model system. Altogether, HepG2BD cells will be instrumental to evaluate, in vitro, the fundamental HBV-HDV interplay during simultaneous chronic replication as well as for antivirals screening targeting both viruses.

Type de document:	Article
Mots-clés libres:	CRISPR-Cas9; HBV; HDV; Antiviral; Cell line
Centre:	Centre INRS-Institut Armand Frappier
Date de dépôt:	29 avr. 2024 14:26
Dernière modification:	29 avr. 2024 14:26
URI:	https://espace.inrs.ca/id/eprint/15626

Gestion Actions (Identification requise)

Modifier la notice